ABCG2 and cancer: Because ABC transporter activity is dependent on ATP [5], [16] and because ATP production in cancer cells is largely dependent on enhanced glycolysis [10], [11], [12], [14], [15], we hypothesized that inhibition of glycolysis can induce a cancer-specific inactivation of ABC transporter activity to restore susceptibility to anti-cancer drugs.